A recent study suggests that patients who stop using popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight far faster than those who end conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while obese people often shed substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs need to be aware of the danger of fast rebound weight gain when the treatment ends," stated lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment weight in about one and a half years.
Analyzing Treatments
The study, which looked at dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Researchers point out that individuals who lose weight through dieting usually experience a less rapid weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Doctors suggest the mechanism of the jabs explains the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than normal may cause the system to produce less of its own natural hormone, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to hunger is uncontrolled, making excessive eating far more likely."
A Chronic Condition?
Medical guidelines suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals say that, considering the significant potential of weight regain, the treatment might need to be life-long.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the medication explain a powerful resurgence of hunger.
"It was like something activating and I was suddenly extremely hungry," recalled an individual.
This challenge is exacerbated if individuals have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Use
Survey data suggest that millions of people in the UK have tried these injections in the past year, with interest being substantial.
- Use is higher among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success hinges on combined lifestyle changes.
